Director, Global Market Access and Pricing Strategy, Oncology

Role Overview

• Lead the development and execution of an integrated Global Market Access and Pricing strategy for one or more therapeutic areas targeted by Pumitamig, spanning late-stage development, launch, and lifecycle management.
• Serve as the Global Market Access lead to the Global Product Team, ensuring payer perspectives are embedded early and consistently into development and commercial strategies, including optimization of registrational trial designs through governance forums (e.g. DEX).
• Ensure robust, forward-looking evidence generation plans are in place to meet evolving payer and HTA requirements across key markets.
• Collaborate across the full Global Market Access organization (Pricing, HEOR, regional and local access teams) to holistically assess Pumitamig opportunities, balancing speed to access, sustainability of value, pricing discipline and long-term franchise considerations, while accounting for anticipated market, policy, and competitive dynamics at launch and beyond.
• Lead the Global Market Access Core Value Team and Value Strategy Team for assigned assets or indications, ensuring alignment across functions and geographies and driving clear strategic direction, prioritization, and execution.
• Partner with Commercial, Medical Affairs, Business Insights & Analytics, and regional teams to continuously monitor the external environment and synthesize insights to inform and adapt Market Access strategy across the asset lifecycle, from late development milestones through commercialization.
• Effectively lead and influence within a highly matrixed and alliance-based environment, building strong, trust-based relationships across functions and with BioNTech partners to enable aligned decision-making, consistent strategy execution, best-practice sharing, and seamless implementation of Global Market Access initiatives in support of shared program objectives.

Requirements

• Bachelor’s degree required in a relevant field; advanced degree (e.g. PharmD, MD, PhD, MSc, MBA) preferred.
• Deep understanding of the current and evolving global market access environment for oncology products, including pricing, reimbursement, and HEOR frameworks, and how these can be leveraged to advance differentiated payer value propositions.
• 8+ years of experience in market access, pricing, HEOR, or related roles within the healthcare or biopharmaceutical industry.
• Strong knowledge of the drug development and commercialization process, supported by a solid scientific background or equivalent experience enabling assessment of clinical development plans from a payer perspective.
• Demonstrated ability to interpret and critically evaluate clinical trial designs, endpoints, and evidence implications for access.
• Launch and/or late-stage development experience is strongly preferred.
• Demonstrated business and financial acumen, with the ability to assess complex strategic trade-offs, synthesize multiple perspectives, and distil clear, pragmatic recommendations to support senior-level decision-making.
• Proven ability to clearly and credibly articulate global access strategy to senior, cross-functional stakeholders, including audiences with varying levels of familiarity with market access dynamics across disease areas or geographies.
• Demonstrated success leading and influencing cross-functional, matrixed teams, with the confidence and judgment to constructively challenge partners and drive alignment when needed.
• High degree of effectiveness in navigating international, multi-cultural, and cross-organizational environments, including experience working across regions and, ideally, within alliance or partnership settings.
• Strong prioritization and execution skills, with experience managing multiple strategic initiatives in parallel while delivering high-quality outcomes in a timely manner.
• Comfortable operating in a rapidly evolving scientific, competitive, and policy landscape, with the ability to manage ambiguity and adapt strategy as new information emerges.
• Willingness and ability to travel as required to international congresses, alliance interactions, and internal BMS meetings.

Benefits

• Health Coverage: Medical, pharmacy, dental, and vision care.
• Wellbeing Support: Programs such as BMS Well-Being Account, BMS Living Life Better, and Employee Assistance Programs (EAP).
• Financial Well-being and Protection: 401(k) plan, short
• and long-term disability, life insurance, accident insurance, supplemental health insurance, business travel protection, personal liability protection, identity theft benefit, legal support, and survivor support.
• Work-life benefits include: Paid Time Off US Exempt Employees: flexible time off (unlimited, with manager approval, 11 paid national holidays (not applicable to employees in Phoenix, AZ, Puerto Rico or Rayzebio employees) Phoenix, AZ, Puerto Rico and Rayzebio Exempt, Non-Exempt, Hourly Employees: 160 hours annual paid vacation for new hires with manager approval, 11 national holidays, and 3 optional holidays Based on eligibility*, additional time off for employees may include unlimited paid sick time, up to 2 paid volunteer days per year, summer hours flexibility, leaves of absence for medical, personal, parental, caregiver, bereavement, and military needs and an annual Global Shutdown between Christmas and New Years Day.